PAVM has been successfully added to your Stock Email Alerts list.
You can manage your stock email alerts here.
PAVM has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
6-1 Month Momentum % is the total return of the stock from 6-month ago to 1-month ago. As of today (2025-03-14), PAVmed's 6-1 Month Momentum % is -62.98%.
The industry rank for PAVmed's 6-1 Month Momentum % or its related term are showing as below:
For the Medical Devices subindustry, PAVmed's 6-1 Month Momentum %, along with its competitors' market caps and 6-1 Month Momentum % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
For the Medical Devices & Instruments industry and Healthcare sector, PAVmed's 6-1 Month Momentum % distribution charts can be found below:
* The bar in red indicates where PAVmed's 6-1 Month Momentum % falls into.
6-1 Month Momentum % is calculated as following:
6-1 Month Momentum % | = | ( Price 1-month ago | / | Price 6-month ago | - 1 ) | * | 100 % |
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
PAVmed (NAS:PAVM) 6-1 Month Momentum % Explanation
Momentum investing is a trading strategy in which investors buy securities that are rising and sell before the prices start to go back down. The 6-1 Month Momentum % measures the total return to a stock over the past six months, but ignores the previous month.
The reason why the most recent month’s return dropped related to the short-term reversal effect associated with momentum. There is an academic finding that short-term momentum actually has a reversal effect, whereby the previous winners (measured over the past months) do poorly the next month, while the previous losers do well the next month. In order to eliminate the short-term reversal effect, the previous month return was not included in this calculation.
Thank you for viewing the detailed overview of PAVmed's 6-1 Month Momentum % provided by GuruFocus.com. Please click on the following links to see related term pages.
Michael J Glennon | director | 420 LEXINGTON AVENUE, SUITE 300, NEW YORK NY 10170 |
Michael Adam Gordon | officer: General Counsel | ONE GRAND CENTRAL PLACE, SUITE 4600, NEW YORK NY 10165 |
Shaun O'neil | officer: Chief Operating Officer | ONE GRAND CENTRAL PLACE, SUITE 4600, NEW YORK NY 10165 |
James L Cox | director | 420 LEXINGTON AVENUE, SUITE 300, NEW YORK NY 10170 |
Debra White | director | C/O PAVMED INC., ONE GRAND CENTRAL PLACE, SUITE 4600, NEW YORK NY 10165 |
Ronald M Sparks | director | 420 LEXINGTON AVENUE, SUITE 300, NEW YORK NY 10170 |
Brian J. Deguzman | officer: Chief Medical Officer | 420 LEXINGTON AVENUE, SUITE 300, NEW YORK NY 10170 |
Dennis M Mcgrath | officer: President & CFO | C/O PAVMED INC., ONE GRAND CENTRAL PLACE, STE. 4600, NEW YORK NY 10165 |
Lishan Aklog | director, 10 percent owner, officer: Chairman and CEO | 420 LEXINGTON AVENUE, SUITE 300, NEW YORK NY 10171 |
Joan B Harvey | director | ONE GRAND CENTRAL PLACE, SUITE 4600, NEW YORK NY 10165 |
Timothy E Baxter | director | ONE GRAND CENTRAL PLACE, SUITE 4600, NEW YORK NY 10165 |
Matthew Sirovich | 10 percent owner | C/O SCOPIA MANAGEMENT INC, 450 SEVENTH AVENUE, 43RD FLOOR, NEW YORK NY 10123 |
Ira Scott Greenspan | director | 888 SEVENTH AVENUE, 9TH FLOOR, NEW YORK NY 10106 |
David S. Battleman | director | C/O TRUENORTH LIFESCIENCES, 348 WEST 57TH STREET, #226, NEW YORK NY 10019 |
Joshua R Lamstein | director | 420 LEXINGTON AVENUE, SUITE 300, NEW YORK NY 10170 |
From GuruFocus
By GuruFocus Research • 03-28-2024
By GuruFocus Research • 02-08-2024
By GuruFocus Research • 08-14-2024
By PRNewswire • 06-13-2024
By PRNewswire • 10-10-2024
By PRNewswire • 08-13-2024
By GuruFocus Research • 09-09-2024
By GuruFocus Research • 02-08-2024
By PRNewswire • 03-13-2024
By GuruFocus Research • 05-15-2024
Disclaimers: GuruFocus.com is not operated by a broker or a dealer. It has an affiliated registered investment adviser, which serves as the subadviser to an exchange traded fund. This investment adviser does not provide advice to individual investors. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes provided by InterActive Data. Fundamental company data provided by Morningstar, updated daily.